You can confide MDSM’s preclinical study
The well known organization called the Medistem Laboratories or the MDSM based at Phoenix in Ariz through its latest press declaration has confirmed about the completion of the preclinical proof-of-concept studies that has been highly successful in the demonstration of the positive potential of its MDS-786 candidate drug that has been specially made and prescribed for lung cancer. It is at the International Society for Cellular Therapy meeting in Sydney, Australia that the findings were presented.
More »
